9 արդյունքներ
TECHNICAL FIELD OF THE INVENTION
This invention relates to the field of substances which have anti-inflammatory or anti-tumor activity and to diagnostic testing of patients for regulation of tumor necrosis factor and elastase activity.
BACKGROUND OF THE INVENTION
Tumor necrosis factor (TNF) is an
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to methods for preventing the emergence of multidrug resistance in tumor cells during cancer chemotherapy. In particular, it relates to the use of inhibitors of particular pathways of signal transduction to prevent the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a tumor marker for diagnosis of cancer, especially for diagnosis of ovarian cancer, which can be applied in early diagnosis of ovarian cancer.
2. The Prior Arts
Human ovarian cancer is one of the common
FIELD
The field of the invention relates to calcium/calmodulin dependent protein kinase II (CaMKII). In particular, the field relates to methods for detecting oxidized forms of CaMKII in order to characterize or diagnose a disease or condition. The field also relates to methods for modulating the
FIELD
The field of the invention relates to calcium/calmodulin dependent protein kinase II (CaMKII). In particular, the field relates to methods for detecting oxidized forms of CaMKII in order to characterize or diagnose a disease or condition. The field also relates to methods for modulating the
FIELD OF THE INVENTION
The present invention relates to the field of gastric cancer. More specifically, the present invention provides methods and compositions for diagnosing and treating gastric cancer.
BACKGROUND OF THE INVENTION
Gastric cancer (GC), a disease with a very poor prognosis, is the
FIELD
The disclosure relates to cancer, including diagnostic markers of cancer, methods for the diagnosis of cancer, methods and compounds for the treatment of cancer, methods for identifying cancer stage in a subject, methods for identifying a cancer that is responsive to particular therapies, and
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to methods of identification of stem cells, and more particularly, but not by way of limitation, to methods of identification
BACKGROUND
(a) Technical Field
The present invention relates to a phenothiazine derivative having CaM inhibitory activity, a method of preparing a compound selected therefrom, and a pharmaceutical composition containing the compound as an active ingredient for preventing and treating lung